We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 134 results
  1. Piperlongumine, a piper alkaloid, enhances the efficacy of doxorubicin in breast cancer: involvement of glucose import, ROS, NF-κB and lncRNAs

    Piperlongumine (PL, piplartine) is an alkaloid derived from the Piper longum L. (long pepper) roots. Originally discovered in 1961, the biological...

    Nikee Awasthee, Anusmita Shekher, ... Subash C. Gupta in Apoptosis
    Article 04 February 2022
  2. General Strategies for Rational Design and Discovery of Multitarget Drugs

    The first step for drug discovery and development is to choose a right or optimal strategy to begin with. This is more so for rational design of...
    Zhiguo Wang, Baofeng Yang in Polypharmacology
    Chapter 2022
  3. Comparison of Therapeutic Efficacy of Nanoformulations of Curcumin vs Tetrahydrocurcumin in Various Disorders

    The purpose of this chapter is to consolidate the existing data on nanoformulation(s) of two folklore molecules, curcumin and tetrahydrocurcumin...
    Vandita Kakkar, Komal Saini, ... Ishaan Duggal in Nanoformulations in Human Health
    Chapter 2020
  4. Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches

    Background

    Glioblastoma, or glioblastoma multiforme (GBM), remains a fatal cancer type despite the remarkable progress in understanding the genesis...

    Manasa Manjunath Hegde, Suma Prabhu, ... B. S. Satish Rao in Journal of Pharmaceutical Investigation
    Article Open access 08 November 2021
  5. The Emerging Role of Natural Products in Cancer Treatment

    The exploration of natural products as potential agents for cancer treatment has garnered significant attention in recent years. In this...

    Sumit Ghosh, Sanjib Kumar Das, ... Parames C. Sil in Archives of Toxicology
    Article 25 May 2024
  6. Notch Pathway: A Journey from Notching Phenotypes to Cancer Immunotherapy

    Notch is a key evolutionary conserved pathway, which has fascinated and engaged the work of investigators in an uncountable number of biological...
    Giulia Monticone, Lucio Miele in Notch Signaling in Embryology and Cancer
    Chapter 2021
  7. Homing Peptides for Cancer Therapy

    Tumor-homing peptides are widely used for improving tumor selectivity of anticancer drugs and imaging agents. The goal is to increase tumor uptake...
    Prakash Lingasamy, Tambet Teesalu in Bio-Nanomedicine for Cancer Therapy
    Chapter 2021
  8. Design and synthesis of ludartin derivatives as potential anticancer agents against hepatocellular carcinoma

    Our previous study demonstrated that guaiane-type sesquiterpenoid ludartin showed potent antihepatoma activity against two human hepatocellular...

    **-** Sun, **-** Wang, ... Ji-Jun Chen in Medicinal Chemistry Research
    Article 24 May 2022
  9. BTK targeting suppresses inflammatory genes and ameliorates insulin resistance

    Type 2 diabetes (T2D) causes profound psychological and physical distress to patients and burdens the health-care system. Although several...

    Mohammad Althubiti, Riyad Almaimani, ... Mahmoud Zaki El-Readi in European Cytokine Network
    Article 01 December 2020
  10. A Practical Guide to miRNA Target Prediction

    MicroRNAs (miRNAs) are small endogenous noncoding RNA molecules that posttranscriptionally regulate gene expression. Since their discovery, a huge...
    Most Mauluda Akhtar, Luigina Micolucci, ... Antonio Domenico Procopio in MicroRNA Target Identification
    Protocol 2019
  11. Exploration of interaction scoring criteria in the CANDO platform

    Objective

    Ascertain the optimal interaction scoring criteria for the Computational Analysis of Novel Drug Opportunities (CANDO) platform for shotgun...

    Zackary Falls, William Mangione, ... Ram Samudrala in BMC Research Notes
    Article Open access 07 June 2019
  12. In Vitro Assays for Assessing Potential Adverse Effects of Cancer Immunotherapeutics

    The field of cancer immunotherapy (CIT) covers a wide and ever-growing variety of molecular platforms and modalities. Since the overall aim of CIT is...
    **ze Li, Mayur S. Mitra, Gautham K. Rao in Immuno-Oncology
    Protocol 2020
  13. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance

    The tumor microenvironment (TME) plays a pivotal role in cancer development and progression. In this line, revealing the precise mechanisms of the...

    Sajad Fakhri, Seyed Zachariah Moradi, ... Anupam Bishayee in Cancer and Metastasis Reviews
    Article 28 July 2023
  14. Natural compounds targeting nuclear receptors for effective cancer therapy

    Human nuclear receptors (NRs) are a family of forty-eight transcription factors that modulate gene expression both spatially and temporally. Numerous...

    Mangala Hegde, Sosmitha Girisa, ... Ajaikumar B. Kunnumakkara in Cancer and Metastasis Reviews
    Article 08 December 2022
  15. Thymoquinone-chemotherapeutic combinations: new regimen to combat cancer and cancer stem cells

    Cancer is a worldwide disease that causes millions of cases of mortality and morbidity. The major problem associated with the cancer is its...

    Ali H. El-Far, Mohamed A. Tantawy, ... Shaker A. Mousa in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 26 May 2020
  16. Genetic engineering of T cells for immunotherapy

    Genetically engineered T cell immunotherapies have provided remarkable clinical success to treat B cell acute lymphoblastic leukaemia by harnessing a...

    Gavin I. Ellis, Neil C. Sheppard, James L. Riley in Nature Reviews Genetics
    Article 18 February 2021
  17. Soluble ligands as drug targets

    Historically, the main classes of drug targets have been receptors, enzymes, ion channels and transporters. However, owing largely to the rise of...

    Misty M. Attwood, Jörgen Jonsson, ... Helgi B. Schiöth in Nature Reviews Drug Discovery
    Article 02 September 2020
  18. ACT001 modulates the NF-κB/MnSOD/ROS axis by targeting IKKβ to inhibit glioblastoma cell growth

    Abstract

    Glioblastomas are high-grade brain tumors with poor prognoses, and new therapeutic approaches for these tumors are critically needed. This...

    Qiuying Li, Yu Sun, ... Zhenzhou Wu in Journal of Molecular Medicine
    Article 04 January 2020
  19. Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells

    Cancer cell growth is associated with immune surveillance failure. Nowadays, restoring the desired immune response against cancer cells remains a...

    Jean-François Rossi, Patrice Céballos, Zhao-Yang Lu in Cancer Communications
    Article Open access 14 June 2019
  20. Inhibition of Tumor Angiogenesis in the Treatment of Lung Cancer

    Several anti-angiogenic drugs have been investigated in patients with thoracic malignancies. In patients with advanced, non-squamous, non-small-cell...
    Massimo Di Maio, Silvia Novello, ... Giorgio Vittorio Scagliotti in Tumor Angiogenesis
    Reference work entry 2019
Did you find what you were looking for? Share feedback.